Hims & Hers Health (HIMS) Enterprise Value (2019 - 2026)
Hims & Hers Health (HIMS) posted Enterprise Value of -$750.9 million for Q1 2026, down 30.02% sequentially from -$577.5 million in Q4 2025, and down 132.71% YoY from $2.3 billion in Q1 2025.
Hims & Hers Health (HIMS) Enterprise Value (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Enterprise Value for 8 years, with the latest figure at -$750.9 million in Q1 2026.
- Quarterly Enterprise Value fell 132.71% year-over-year to -$750.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$750.9 million (down 132.71% YoY) and the FY2025 annual result came in at -$577.5 million, down 92.34% from the prior year.
- Enterprise Value slipped to -$750.9 million in Q1 2026 per HIMS's latest filing, from -$577.5 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$179.6 million in Q4 2022 and troughed at -$1.1 billion in Q2 2025.
- A 5-year average of -$352.8 million and a median of -$221.0 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value jumped 38.56% in 2022, then tumbled 403.59% in 2025.
- Over 5 years, Enterprise Value stood at -$179.6 million in 2022, then slipped by 23.02% to -$221.0 million in 2023, then tumbled by 35.87% to -$300.3 million in 2024, then sank by 92.34% to -$577.5 million in 2025, then slumped by 30.02% to -$750.9 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$750.9 million, -$577.5 million, and -$629.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | -841.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -841.05 Mn |
| Mar 31, 2026 | -750.88 Mn |
| Dec 31, 2025 | -577.49 Mn |
| Sep 30, 2025 | -629.74 Mn |
| Jun 30, 2025 | -1.14 Bn |
| Mar 31, 2025 | -322.67 Mn |
| Dec 31, 2024 | -300.25 Mn |
| Sep 30, 2024 | -254.07 Mn |
| Jun 30, 2024 | -227.29 Mn |
| Mar 31, 2024 | -203.59 Mn |
| Dec 31, 2023 | -220.98 Mn |
| Sep 30, 2023 | -212.50 Mn |
| Jun 30, 2023 | -193.14 Mn |
| Mar 31, 2023 | -184.39 Mn |
| Dec 31, 2022 | -179.63 Mn |
| Sep 30, 2022 | -198.39 Mn |
| Jun 30, 2022 | -194.98 Mn |
| Mar 31, 2022 | -203.05 Mn |
| Dec 31, 2021 | -247.27 Mn |
| Sep 30, 2021 | -252.43 Mn |